Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV. (2022)
Attributed to:
Natural Killer Cells as Effectors in HIV Cure Strategies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1172/jci.insight.157031
PubMed Identifier: 35192543
Publication URI: http://europepmc.org/abstract/MED/35192543
Type: Journal Article/Review
Volume: 7
Parent Publication: JCI insight
Issue: 7
ISSN: 2379-3708